Glycorex Transplantation
0.85 SEK +6.25%Be the first to follow this company
Glycorex Transplantation is a biotechnology company. The company conducts research, development, and marketing within the field of organ transplantation. The main product of the company, Glycosorb-ABO, enables transplants irrespective of the blood type of the donors and the recipients. Transplants with the help of the company's product have been carried out worldwide. Glycorex Transplantation was founded in 1996 and is based in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NGM Main Regulated
GTAB B
Daily low / high price
0.76 / 0.85
SEK
Market cap
62.78M SEK
Turnover
72.16K SEK
Volume
92K
Financial calendar
Interim report
2024-08-29
Interim report
2024-11-28
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 10.9 % | 7.8 % |
Wendt Investment AB | 7.1 % | 5.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Glycorex Transplantation AB (GTAB B): Delårsrapport januari - mars 2024
Glycorex Transplantation: Glycosorb® ABO tänjer gränserna inom blodgruppsinkompatibla pediatriska hjärttransplantationer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools